MedTech Strategist Issue: Vol. 5, No. 9 - June 27, 2018


Already a Subscriber?


Not a Subscriber?


Executive Interview - "Charting Baxter’s Rebound: An Interview with CEO Joe Almeida"

By David Cassak, Co-Editor-in-Chief

Three decades ago, Baxter International was a leader in a medical device industry that was more about low tech medical supplies than high tech devices. As the industry itself transformed, however, Baxter began to lose its way, to lose its innovative edge.  In 2016, former Covidien CEO Joe Almeida came on board as Baxter’s new CEO, bringing a fresh vision for innovation to this once-dynamic company.

Orthobiologics - "Orthopedics Grapples with Evidence-Based Use of Stem-Cell Therapies"

By Wendy Diller, Senior Writer/Market Analyst

The stem-cell therapies market is booming, thanks to ongoing unmet clinical needs, demographics, marketing, and advances in technology, but medical professionals are grappling with lack of evidence for most applications.



Outside Opinion - Hospital Partnerships: "Good News, Bad News: Hospitals Want to Partner"

By Jonas Funk, Monish Rajpal, and Ilya Trakhtenberg, Contributing Writers

Hospitals and health systems are expanding their use of external partnerships and while medtech companies don’t lead the list of preferred partners, a recent survey from LEK Consulting indicates that relationships with medtechs are becoming a high priority, particularly for progressive health systems.

Outside Opinion - "Driving Medical Device Sales and Profit Growth by Creating Mega-5’s"

By John Larson, Contributing Writer

Instead of expending sales and marketing energy on dissatisfied customers, medical device companies should deepen their relationship with already highly-satisfied customers. Although targeting them requires a challenging shift in salesforce strategy, these “Mega-5” customers are a medtech’s best shot at boosting sales and profits.



Start-Ups To Watch - Augmented Reality in Cardiology: "SentiAR: Intraprocedural, Real-Time Augmented Reality Enhances Catheter Ablation"

By Mary Stuart, Senior Writer/Market Analyst

SentiAR aims to improve the workflow, ergonomics and precision of catheter ablation for the treatment of atrial fibrillation, by presenting clinicians with a three-dimensional image of a patient’s heart and the location of their catheter within that model during surgery.

Start-Ups To Watch - Post-Operative Management: "Output Medical: Predicting Acute Kidney Injury Right on Time"

By Colin Miller, Contributing Writer

Output's premier application is a means of automating the measurement of urine output in hospital patients to better monitor their risk of acute kidney injury, or AKI, as low-trending output can be a telltale diagnostic factor.


Not a Subscriber?

Already a Subscriber?

Want a Sample Article?

Companies Covered in this Issue:  Abbott Vascular, Astute Medical Inc., AveXis Inc., AuriGen Medical, Baxter International Inc., Biomodex, Boston Scientific Corp., CardioCorX, Cardiologs Technologies SAS, Celularity Inc., CorFlow Therapeutics AG, Elixir Medical Corp., Endotronix Inc., FEops NV, Hartlon, HealthWatch Technologies, Japan Medical Device Technology Ltd., Johnson & Johnson, Magenta Medical, Medtronic PLC, MiMedix, Novartis AG, Output Medical Inc., Paragate Medical, Pi-Cardia Ltd., Procyrion Inc., Royal Philips Electronics NV, S-Bahn Medical, SentiAr Inc., Sequana Medical AG, ShockWave Medical Inc., Stentit, Vericel Corp., Xeltis BV

Topics Covered in this Issue:  Biomaterials/Biotechnology; Cardiovascular/Vascular; Critical Care/Emergency Medicine/ICU; Executive Interviews, Health Information Technology/Digital Health; Healthcare Delivery/Providers/Payors; Imaging; Investment/Finance/M&As; Medtech Business Strategies/Development; Orthopedics/Spine; Patient Monitoring; Perspective/Commentary; Regenerative Medicine/Cell Therapy; Start-Ups; Urology/Renal Disease